Femara

Femara (Letrozole) is a medication used to treat certain types of breast cancer. It works by reducing estrogen levels in the body, which can help slow the growth of cancer cells.

Femara is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is often prescribed after surgery or other treatments to help prevent the cancer from returning. The medication is designed to inhibit the enzyme aromatase, which is responsible for producing estrogen. This reduction in estrogen can slow the progression of breast cancer cells that rely on this hormone to grow.

Common effects of Femara may include hot flashes, joint pain, fatigue, and hair thinning. Some users might experience nausea, dizziness, or swelling in the hands or feet. These effects can vary from person to person and may not affect everyone who takes the medication.

Femara should be used with caution in individuals with a history of osteoporosis or liver disease. It is important to discuss any pre-existing conditions with a healthcare provider before starting this medication. Regular monitoring may be recommended to assess bone health and liver function during treatment.

Femara may interact with certain medications, including estrogen-containing therapies and some types of cholesterol-lowering drugs. It is advisable to inform a healthcare provider about all current medications to avoid potential interactions. Alcohol consumption should also be discussed, as it may affect the body's response to the medication.